trending Market Intelligence /marketintelligence/en/news-insights/trending/WH3mPQK7t9KPPDV4dNreTA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Underwriters for Verona Pharma offering further exercise overallotment option

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Underwriters for Verona Pharma offering further exercise overallotment option

Underwriters for Verona Pharma PLC's global offering of American depositary shares, or ADS, and ordinary shares further exercised their overallotment option, and will buy an additional 41,353 ADS at $13.50 apiece.

The company will raise an additional $600,000 in gross proceeds from the further exercise of the option, for total gross proceeds of about $89.9 million. After the closing of the further exercise of the overallotment option, which is expected May 26, Verona Pharma will have sold 6,501,738 ADS.

Jefferies and Stifel acted as joint book-running managers for the global offering with Wedbush PacGrow and SunTrust Robinson Humphrey acting as co-managers.